Connection

David Koch to Biomarkers

Back to Details
This is a "connection" page, showing publications David Koch has written about Biomarkers.
David Koch
Connection Strength
0.064
Biomarkers
  1. Sorafenib in Hepatopulmonary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Liver Transpl. 2019 08; 25(8):1155-1164.
    View in: PubMed
    Score: 0.028
  2. Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease. Alcohol Clin Exp Res. 2014 Jun; 38(6):1706-11.
    View in: PubMed
    Score: 0.019
  3. Sensitivity and specificity of urinary ethyl glucuronide and ethyl sulfate in liver disease patients. Alcohol Clin Exp Res. 2013 Jan; 37(1):150-5.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.